LNWTC
ELV icon

Laird Norton Wetherby Trust Company’s Elevance Health ELV Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19M Sell
7,477
-852
-10% -$280K 0.05% 302
2025
Q4 		$2.92M Buy
+8,329
New +$2.81M 0.06% 245

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Laird Norton Wetherby Trust Company's ELV Position: Q1 2026 in Review

Laird Norton Wetherby Trust Company reduced its Elevance Health (ELV) stake by 10% in Q1 2026, selling an estimated $280K and leaving 7,477 shares worth $2.19M. The position accounts for 0.05% of the portfolio, ranked #302.

Laird Norton Wetherby Trust Company first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.92M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Laird Norton Wetherby Trust Company held 7,477 shares of Elevance Health worth $2.19M as of Q1 2026.
  • Laird Norton Wetherby Trust Company sold 852 Elevance Health shares in Q1 2026, an estimated $280K.
  • Elevance Health made up 0.05% of Laird Norton Wetherby Trust Company's portfolio in Q1 2026, its #302 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
  • Laird Norton Wetherby Trust Company's Elevance Health position peaked at $2.92M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2026, filed 15 May 2026.